FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 44.10
-0.40 (-0.90%)
Jun 12, 2026, 4:51 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 721 million as of June 12, 2026. Its market cap has increased by 22.54% in one year.
Market Cap
721.00M
Enterprise Value
669.16M
Revenue
349.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
44.10
Market Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 721.00M, an increase of 1,701.50%. That is a compound annual growth rate of 50.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 721.00M | 28.57% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 930.82M |
| Infant Bacterial Therapeutics AB | 821.76M |
| SynAct Pharma AB | 771.60M |
| Xspray Pharma AB | 717.89M |
| Oncopeptides AB | 699.66M |
| Cantargia AB | 537.00M |
| AlzeCure Pharma AB | 491.83M |